Literature DB >> 23218784

Refractory giardiasis in Spanish travellers.

Jose Muñoz Gutiérrez1, Edelweiss Aldasoro, Ana Requena, Ana M Comin, Maria Jesús Pinazo, Azucena Bardají, Inés Oliveira, Maria Eugenia Valls, Joaquim Gascon.   

Abstract

Drug failure is a common cause of symptom persistence after treatment of imported Giardia duodenalis. In this retrospective study we describe a high prevalence of refractory giardiasis in people attended in a travel clinic in Spain, especially those with infections acquired in Asia. Moreover, we discuss various treatment strategies to tackle G. duodenalis that is refractory to nitroimidazoles.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23218784     DOI： 10.1016/j.tmaid.2012.10.004

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN： 1477-8939            Impact factor:   6.211


  15 in total

Review 1.  Understanding drug resistance in human intestinal protozoa.

Authors:  Hend Aly El-Taweel
Journal:  Parasitol Res       Date:  2015-03-19       Impact factor: 2.289

2.  Prebiotic inulin supplementation modulates the immune response and restores gut morphology in Giardia duodenalis-infected malnourished mice.

Authors:  Geeta Shukla; Ruchika Bhatia; Anuj Sharma
Journal:  Parasitol Res       Date:  2016-07-30       Impact factor: 2.289

3.  Prophylactic Potential of Synbiotic (Lactobacillus casei and Inulin) in Malnourished Murine Giardiasis: an Immunological and Ultrastructural Study.

Authors:  Geeta Shukla; Anuj Sharma; Ruchika Bhatia; Mridul Sharma
Journal:  Probiotics Antimicrob Proteins       Date:  2019-03       Impact factor: 4.609

Review 4.  Efficacy of 5-nitroimidazoles for the treatment of giardiasis: a systematic review of randomized controlled trials.

Authors:  Vinay Pasupuleti; Angel Arturo Escobedo; Abhishek Deshpande; Priyaleela Thota; Yuani Roman; Adrian V Hernandez
Journal:  PLoS Negl Trop Dis       Date:  2014-03-13

5.  Molecular diversity and frequency of the diarrheagenic enteric protozoan Giardia duodenalis and Cryptosporidium spp. in a hospital setting in Northern Spain.

Authors:  José Manuel Azcona-Gutiérrez; Aida de Lucio; Marta Hernández-de-Mingo; Concepción García-García; Luis Miguel Soria-Blanco; Lucía Morales; María Aguilera; Isabel Fuentes; David Carmena
Journal:  PLoS One       Date:  2017-06-15       Impact factor: 3.240

6.  Proteomic and functional analyses reveal pleiotropic action of the anti-tumoral compound NBDHEX in Giardia duodenalis.

Authors:  Serena Camerini; Alessio Bocedi; Serena Cecchetti; Marialuisa Casella; Miriam Carbo; Veronica Morea; Edoardo Pozio; Giorgio Ricci; Marco Lalle
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-03-29       Impact factor: 4.077

Review 7.  Treatment-refractory giardiasis: challenges and solutions.

Authors:  Marco Lalle; Kurt Hanevik
Journal:  Infect Drug Resist       Date:  2018-10-24       Impact factor: 4.003

8.  Genetic variation in metronidazole metabolism and oxidative stress pathways in clinical Giardia lamblia assemblage A and B isolates.

Authors:  Christina S Saghaug; Christian Klotz; Juha P Kallio; Hans-Richard Brattbakk; Tomasz Stokowy; Toni Aebischer; Inari Kursula; Nina Langeland; Kurt Hanevik
Journal:  Infect Drug Resist       Date:  2019-05-10       Impact factor: 4.003

9.  Molecular Genotyping of Giardia duodenalis Isolates from Symptomatic Individuals Attending Two Major Public Hospitals in Madrid, Spain.

Authors:  Aida de Lucio; Rocío Martínez-Ruiz; Francisco J Merino; Begoña Bailo; María Aguilera; Isabel Fuentes; David Carmena
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

10.  Acute Acalculous Cholecystitis Caused by Giardia lamblia.

Authors:  Hiromichi Araki; Shuya Shimizu; Katsumi Hayashi; Tomonori Yamada; Atsunori Kusakabe; Hiroshi Kanie; Yusuke Mizuno; Issei Kojima; Akitoshi Saitou; Kazuhiro Nagao; Yuka Suzuki; Tadashi Toyohara; Takanori Suzuki; Erika Uchida; Konomu Uno; Takahiro Nakazawa
Journal:  Intern Med       Date:  2017-07-01       Impact factor: 1.271
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.